Great DD SL. Looks legit to me…only thing I am confused about is the 0.5 gm option for V for CVS…
Big question is are they getting back on formulary through undercutting generic pricing or have they put the fear of God (aka infringement by generics) in the insurance companies.
I just wish one of the useless analysts would ask these kinds of questions vs. inane ones by their associates who have no clue. As someone mentioned, the main analysts don’t even bother showing up to the calls anymore…
Market Data 
Markets 
AI
